At Gulf Biotech Company, we specialize in innovative processes to make difficult-to-manufacture specialty and generic drugs that are easier to use, less labor intensive, and more streamlined in practice. GBC ensures that its high-quality FDA-approved drugs fulfill a critical unmet medical need and delivers dependable live-saving treatment options when and where they’re needed most.
Since its inception in 2016, Gulf Biotech has been a pioneer in the generic drug industry. We are a fast-growing company with a robust pipeline that has featured several recent launches of first-to-market FDA-approved specialty drugs, engineered to improve the lives of cardiac patients.